sumatriptan has been researched along with Amnesia-Memory Loss in 2 studies
Sumatriptan: A serotonin agonist that acts selectively at 5HT1 receptors. It is used in the treatment of MIGRAINE DISORDERS.
sumatriptan : A sulfonamide that consists of N,N-dimethyltryptamine bearing an additional (N-methylsulfamoyl)methyl substituent at position 5. Selective agonist for a vascular 5-HT1 receptor subtype (probably a member of the 5-HT1D family). Used (in the form of its succinate salt) for the acute treatment of migraine with or without aura in adults.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, E | 1 |
| Ghafoor, N | 1 |
| Jefri, M | 1 |
| Black, AD | 1 |
| Calello, DP | 1 |
| Santos, CD | 1 |
| Porter, G | 1 |
| Shaw, T | 1 |
| Ryan, CJ | 1 |
2 other studies available for sumatriptan and Amnesia-Memory Loss
| Article | Year |
|---|---|
Acute coronary syndrome and transient global amnesia with sumatriptan.
Topics: Acute Coronary Syndrome; Aged; Amnesia; Amnesia, Transient Global; Female; Humans; Middle Aged; Suma | 2022 |
Fugue associated with migraine.
Topics: Adult; Amnesia; Brain; Humans; Magnetic Resonance Imaging; Male; Migraine with Aura; Sumatriptan; To | 2007 |